Risankizumab in severe asthma: A Phase IIa, placebo-controlled study

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Christopher E. Brightling, Parameswaran Nair, Renaud Louis, Dave Singh

Journal title: The New England Journal of Medicine

Journal publisher: Massachusetts Medical Society

Published year: 2021

DOI identifier: 10.1056/nejmoa2030880

ISSN: 1533-4406